Anton M. Bennett PhD

Professor of Pharmacology and of Comparative Medicine; Co-Director, Program in Integrative Cell Signaling and Neurobiology of Metabolism; Director, BBS Minority Affairs

Departments & Organizations

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Neuroscience | Molecular Cell Biology, Genetics and Development | Molecular Medicine, Pharmacology, and Physiology


Interdepartmental Neuroscience Program

Stem Cell Center, Yale: Tissue Specific Stem Cells

Signal Transduction

Vascular Biology and Therapeutics Program

Comparative Medicine: Integrative Cell Signaling & Neurobiology of Metabolism (ICSNM)

Pharmacology: Neuropharmacology | Bennett Lab

Diabetes Research Center

Yale Core Center for Musculoskeletal Disorders

Research Interests

Signal transduction; Protein tyrosine phosphatases; Cancer; Diabetes; Obesity; Muscle stem cells; Muscular dystrophy


  • Ph.D., New York Medical College , 1993

Selected Publication

  • Shi, H., Verma, M., Zhang, L. Dong, C., Flavell, R.A., and Bennett, A. M. (2013), Improved Regenerative Myogenesis and Muscular Dystrophy in Mice lacking MKP-5, J. Clin. Invest., 123: 2064-2077.

Latest Honor and Recognition

  • Burroughs-Wellcome Award for New Investigators in Pharmacology(2001)